A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.


Updates from The Motley Fool

Latest updates on Merck & Co. from Fool.com.  The Fool has written over 1600 articles on Merck & Co..


Stock Performance

View Interactive MRK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Merck & Co..
Current Price: $62.22
Prev Close: $61.89
Open: $62.50
Bid: $62.26
Ask: $62.27
Day's Range: $62.09 - $62.52
52wk Range: $53.06 - $66.80
Volume: 3,496,311
Avg Vol 8,756,443
Market Cap: $171B
P/E (ttm): 43.89
EPS (ttm): $1.41
Div & Yield: $1.88 (3.0%)

Company Rating

What our community thinks about Merck & Co..
CAPS Rating 4 out of 5
 
2716 Outperform
219 Underperform
CAPS All Stars
 
663 Outperform
33 Underperform

How do you think Merck & Co. will perform against the market?



You pick for Merck & Co. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kenneth C. Frazier, CEO

77% Approve

Based on 777 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Merck & Co..

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers